If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 64   2003   NUMBER 9

Issue to be mailed the week of September 24, 2003

CME Pretest 981

CME Posttest 1137

Brainstorms

982 Deconstructing Psychiatric Disorders, Part 1: Genotypes, Symptom Phenotypes, and Endophenotypes. Stephen M. Stahl
[PDF]

Original Articles

984 Polypharmacy in Patients With Schizophrenia. Robert E. McCue, Rubina Waheed, and Leonel Urcuyo
[Abstract] [PDF]

990 Feeling Unreal: A Depersonalization Disorder Update of 117 Cases. [CME] Daphne Simeon, Margaret Knutelska, Dorothy Nelson, and Orna Guralnik
[Abstract] [PDF]

998 Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years. Peter D. Feldman, Christopher J. Kaiser, John S. Kennedy, Virginia K. Sutton, Pierre V. Tran, Gary D. Tollefson, Fan Zhang, and Alan Breier
[Abstract] [PDF]

1005 Aerobic Endurance Exercise Improves Executive Functions in Depressed Patients. [CME] Sabine Kubesch, Volker Bretschneider, Roland Freudenmann, Niels Weidenhammer, Manfred Lehmann, Manfred Spitzer, and Georg Grön
[Abstract] [PDF]

1013 A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I Disorder. Joseph R. Calabrese, Charles L. Bowden, Gary Sachs, Lakshmi N. Yatham, Kirsten Behnke, Olli-Pekka Mehtonen, Paul Montgomery, John Ascher, Walter Paska, Nancy Earl, and Joseph DeVeaugh-Geiss, for the Lamictal 605 Study Group
[Abstract] [PDF]

1025 Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder. William A. Hewlett, Sabine P. Schmid, and Ronald M. Salomon
[Abstract] [PDF]

1031 Suicide Attempts Among Veterans Seeking Treatment for Pathological Gambling. Otto Kausch
[Abstract] [PDF]

1039 A 3-Year Naturalistic Study of 53 Preschool Children With Pervasive Developmental Disorders Treated With Risperidone. Gabriele Masi, Angela Cosenza, Maria Mucci, and Paola Brovedani
[Abstract] [PDF]

1048 Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic Schizophrenia: A Placebo-Controlled 26-Week Study. Teresa A. Pigott,William H. Carson,Anutosh R. Saha, Anne F. Torbeyns, Elyse G. Stock, and Gary G. Ingenito,for the Aripiprazole Study Group
[Abstract] [PDF]

1057 Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled Study. Charles DeBattista, Karl Doghramji, Matthew A. Menza, Murray H. Rosenthal, and Ronald R. Fieve, for the Modafinil in Depression Study Group
[Abstract] [PDF]

1065 Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression. Mark Hyman Rapaport, Lon S. Schneider, David L. Dunner, John T. Davies, and Cornelius D. Pitts
[Abstract] [PDF]

1075 Incidence of Tardive Dyskinesia in First-Episode Psychosis Patients Treated With Low-Dose Haloperidol. Piet P. Oosthuizen, Robin A. Emsley, J. Stephanus Maritz, Jadri A. Turner, and N. Keyter
[Abstract] [PDF]

1081 Treatment of Previously Undiagnosed Psychiatric Disorders in Persons With Developmental Disabilities Decreased or Eliminated Self-Injurious Behavior. John A. Tsiouris, Ira L. Cohen, Paul J. Patti, and William M. Korosh
[Abstract] [PDF]

1091 How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial? Gabor I. Keitner, Michael A. Posternak, and Christine E. Ryan
[Abstract] [PDF]

1094 Suicidal Ideation and Attempts Among Psychiatric Patients With Major Depressive Disorder. T. Petteri Sokero, Tarja K. Melartin, Heikki J. Rytsälä, Ulla S. Leskelä, Paula S. Lestelä-Mielonen, and Erkki T. Isometsä
[Abstract] [PDF]

1101 Psychoeducation Efficacy in Bipolar Disorders: Beyond Compliance Enhancement. Francesc Colom, Eduard Vieta, María Reinares, Anabel Martínez-Arán, Carla Torrent, José Manuel Goikolea, and Cristòbal Gastó
[Abstract] [PDF]

1106 The Use of Atypical Antipsychotics in Nursing Homes. Rosa Liperoti, Vincent Mor, Kate L. Lapane, Claudio Pedone, Giovanni Gambassi, and Roberto Bernabei
[Abstract] [PDF]

1113 Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine. Eric Hollander, for the Paroxetine OCD Study Group, Andrea Allen, Martin Steiner, David E. Wheadon, Rosemary Oakes, and Daniel B. Burnham
[Abstract] [PDF]

Academic Highlights

1122 Reducing the Risk for Suicide in Schizophrenia and Affective Disorders. [CME]
[PDF]

Letters To the Editor

1130 Underdiagnosis of Bipolar II Disorders in the Community. Franco Benazzi
[PDF]

1131 Charles Bonnet Syndrome With Visual Hallucinations of Childhood Experience: Successful Treatment of 1 Patient With Risperidone. Kazuhisa Maeda, Yukihiko Shirayama, Shu Nukina, Shinichi Yoshioka, and Ryuzo Kawahara
[PDF]

1132 Polypharmacy in Schizophrenia: A Fuzzy Concept. Oliver Freudenreich and Donald C. Goff
[PDF]

  • Reply by Stephen M. Stahl

1133 Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine. Deanna L. Kelly, Julie Kreyenbuhl, Raymond C. Love, Quynh Van-Duong, and Robert R. Conley
[PDF]

Book Reviews 1135

NOW@Psychiatrist.com 1140

Information for authors

see www.psychiatrist.com/author.htm for complete information